These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 25944644)

  • 21. Patient characteristics of suspected mast-cell activation syndrome with sinonasal obstruction: a single institution experience.
    Kim JH; Xi S; Ference EH; Ge M; Liu MM; Wrobel BB
    Int Forum Allergy Rhinol; 2020 Aug; 10(8):996-1000. PubMed ID: 32407593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.
    Butterfield JH; Weiler CR
    Int Arch Allergy Immunol; 2008; 147(4):338-43. PubMed ID: 18622141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mast Cell Activation Syndrome and Gut Dysfunction: Diagnosis and Management.
    Hamilton MJ
    Curr Gastroenterol Rep; 2024 Apr; 26(4):107-114. PubMed ID: 38353900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome.
    Butterfield J; Weiler CR
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2533-2541. PubMed ID: 32142966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tryptase: A practical guide for the physician].
    Lobbes H; Reynaud Q; Mainbourg S; Lega JC; Durieu I; Durupt S
    Rev Med Interne; 2020 Nov; 41(11):748-755. PubMed ID: 32712042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using the Right Criteria for MCAS.
    Gulen T
    Curr Allergy Asthma Rep; 2024 Feb; 24(2):39-51. PubMed ID: 38243020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mast cell activation: beyond histamine and tryptase.
    Theoharides TC; Perlman AI; Twahir A; Kempuraj D
    Expert Rev Clin Immunol; 2023 Jun; 19(6):639-654. PubMed ID: 37029958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mast cell activation syndrome].
    Brockow K
    Hautarzt; 2013 Feb; 64(2):102-6. PubMed ID: 23385621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Approach to Mast Cell Activation Syndrome: A Practical Overview.
    Matito A; Escribese MM; Longo N; Mayorga C; Luengo-Sánchez O; Pérez-Gordo M; Matheu V; Labrador-Horrillo M; Pascal M; Seoane-Reula ME;
    J Investig Allergol Clin Immunol; 2021 Dec; 31(6):461-470. PubMed ID: 33541851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The presence of mast cell clonality in patients with unexplained anaphylaxis.
    Gülen T; Hägglund H; Sander B; Dahlén B; Nilsson G
    Clin Exp Allergy; 2014 Sep; 44(9):1179-87. PubMed ID: 25039926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generalized pruritus relieved by NSAIDs in the setting of mast cell activation syndrome.
    Kesterson K; Nahmias Z; Brestoff JR; Bodet ND; Kau A; Kim BS
    J Allergy Clin Immunol Pract; 2018; 6(6):2130-2131. PubMed ID: 29577987
    [No Abstract]   [Full Text] [Related]  

  • 32. Markers of mast cell degranulation.
    Hogan AD; Schwartz LB
    Methods; 1997 Sep; 13(1):43-52. PubMed ID: 9281467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. H1-antihistamines for primary mast cell activation syndromes: a systematic review.
    Nurmatov UB; Rhatigan E; Simons FE; Sheikh A
    Allergy; 2015 Sep; 70(9):1052-61. PubMed ID: 26095756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Doctor, I Think I Am Suffering from MCAS: Differential Diagnosis and Separating Facts from Fiction.
    Valent P; Akin C
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1109-1114. PubMed ID: 30961836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels.
    Zanotti R; Lombardo C; Passalacqua G; Caimmi C; Bonifacio M; De Matteis G; Perbellini O; Rossini M; Schena D; Busa M; Marcotulli MC; Bilò MB; Franchini M; Marchi G; Simioni L; Bonadonna P
    J Allergy Clin Immunol; 2015 Jul; 136(1):135-9. PubMed ID: 25605272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine.
    Valent P; Akin C; Nedoszytko B; Bonadonna P; Hartmann K; Niedoszytko M; Brockow K; Siebenhaar F; Triggiani M; Arock M; Romantowski J; Górska A; Schwartz LB; Metcalfe DD
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33261124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human mast cell tryptase in biology and medicine.
    Vitte J
    Mol Immunol; 2015 Jan; 63(1):18-24. PubMed ID: 24793463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of plasma heparin level improves identification of systemic mast cell activation disease.
    Vysniauskaite M; Hertfelder HJ; Oldenburg J; Dreßen P; Brettner S; Homann J; Molderings GJ
    PLoS One; 2015; 10(4):e0124912. PubMed ID: 25909362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the role of PGD2 metabolites as markers of mast cell activation in asthma.
    O'Sullivan S
    Acta Physiol Scand Suppl; 1999 Apr; 644():1-74. PubMed ID: 10352758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Idiopathic Anaphylaxis: A Form of Mast Cell Activation Syndrome.
    Giannetti MP; Akin C; Castells M
    J Allergy Clin Immunol Pract; 2020 Apr; 8(4):1196-1201. PubMed ID: 32276688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.